Cancer Gene Therapy via NKG2D and FAS Pathways

doi 10.5772/17386
Full Text
Abstract

Available in full text

Date
Authors
Publisher

InTech

Related search

NKG2D Ligands–Critical Targets for Cancer Immune Escape and Therapy

Frontiers in Immunology
AllergyImmunology
2018English

Antibody-Nkg2d Ligand (Rae-1Beta) Fusion Protein for Breast Cancer Therapy

2005English

Navigating the Fas Lane to Improved Cellular Therapy for Cancer

Journal of Clinical Investigation
Medicine
2019English

Disease Classification via Gene Network Integrating Modules and Pathways

Royal Society Open Science
Multidisciplinary
2019English

Survivin Enhances Fas Ligand Expression via Up-Regulation of Specificity Protein 1-Mediated Gene Transcription in Colon Cancer Cells

Journal of Immunology
AllergyImmunology
2004English

Molecular Pathways: Breaking the Epithelial Cancer Barrier for Chimeric Antigen Receptor and T-Cell Receptor Gene Therapy

Clinical Cancer Research
Cancer ResearchOncology
2016English

Gene Therapy Progress and Prospects: Cancer Gene Therapy Using Tumour Suppressor Genes

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2004English

Gene Therapy of Pancreatic Cancer

Journal of Genetic Syndromes & Gene Therapy
2013English

Gene Therapy for Pancreatic Cancer

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy